Celebrex improved DFS in ctDNA-positive colon cancer patients, reducing cancer recurrence and death risk by 37% compared to placebo. ctDNA status post-surgery was highly prognostic of DFS and OS, ...
Background: Non-steroidal anti-inflammatory drugs (NSAIDs) are recommended for multimodal postoperative pain management. We evaluated opioid-sparing effects and rehabilitative results after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback